Gastrointestinal Cancer and Other Gastrointestinal Disease: Molecular Biology, Targeted Therapy and Prognostic Value
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Molecular Targeted Therapy".
Deadline for manuscript submissions: closed (15 May 2024) | Viewed by 449
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gastrointestinal diseases refer to diseases of the digestive tract consisting of the esophagus, stomach, small intestine, large intestine and rectum, liver, pancreas, and gallbladder. Gastrointestinal diseases such as eosinophilic esophagitis, Barrett’s esophagus, gastroesophageal reflux disease, gallstones, inflammatory bowel syndrome, irritable bowel syndrome and gastrointestinal tumors are common gastrointestinal diseases and they pose a significant threat to human health. Among gastrointestinal tumors, colorectal cancer and gastric cancer are the third and fifth most common cancer types, respectively, and one of the fifth leading causes of cancer-related deaths worldwide. Therefore, early diagnosis provides patients with the best chance of treatment and greatly improves their prognosis.
Recent advances in current cellular and molecular biology have greatly elucidated the pathophysiology of the gastrointestinal tract from injury and repair to reperfusion injury to chronic inflammatory states. New techniques and work are helping us identify novel mechanisms of gastrointestinal disease pathophysiology, thereby providing potential new targets for therapeutic intervention.
We invite you to contribute to the Special Issue entitled “Gastrointestinal Cancer and Other Gastrointestinal Disease: Molecular Biology, Targeted Therapy and Prognostic Value”. This Special Issue will showcase the exciting new work in this field that may herald future treatments. We hope you will consider contributing a manuscript to this Special Issue.
Dr. Stanley Lightfoot
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastrointestinal disease
- gastrointestinal cancer
- targeted therapy
- prognostic value
- personalized medicine
- functional disorders
- inflammation
